Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

Bo Han, Rohit Mehra, Khalid Suleman, Scott A. Tomlins, Lei Wang, Nishi Singhal, Katherine A. Linetzky, Nallasivam Palanisamy, Ming Zhou, Arul M. Chinnaiyan, Rajal B. Shah

Research output: Contribution to journalArticle

76 Scopus citations

Abstract

Histologic variants of prostate carcinoma account for 5-10% of the disease and are typically seen in association with conventional acinar carcinoma. These variants often differ from the latter in clinical, immunophenotypic, and biologic potential. Recently, recurrent gene fusions between the androgen-regulated gene TMPRSS2 and the ETS transcription factors ERG, ETV1, ETV4, or ETV5 have been identified in a majority of conventional prostate carcinomas. However, the frequency and significance of this critical molecular event is unknown in the histologic variants of prostate carcinoma. Here, we used break-apart fluorescence in situ hybridization to assess TMPRSS2 and ETS aberrations in a series of select histologic variants: foamy gland carcinoma (N=17), ductal adenocarcinoma (N=18), mucinous carcinoma (N=18), and small cell carcinoma (N=7). A histologic variation of acinar adenocarcinoma, demonstrating glomeruloid morphology (N=9), was also investigated. Overall, 55% of histologic variant or variation morphologies demonstrated ETS aberrations (ERG in 54% and ETV1 in 1%). TMPRSS2:ERG fusion was identified in 83% (15/18), 71% (5/7), 50% (9/18), 33% (3/9), and 29% (5/17) of mucinous, small cell, ductal, glomeruloid, and foamy gland prostate carcinomas, respectively. Previously, we reported that 100% of androgen-independent metastatic prostate carcinomas harboring TMPRSS2:ERG gene fusion were associated with interstitial deletion (Edel). Interestingly, ERG rearrangement in small cell carcinomas occurred exclusively through Edel, supporting the notion that TMPRSS2:ERG with Edel is an aggressive molecular subtype. SPINK1, a biomarker expressed exclusively in a subset of ETS negative prostate carcinomas, was expressed in 6% of ETS negative histologic variants, specifically in ductal adenocarcinoma. Notably, 88% (43/49) variant morphologies in this cohort showed concordance of TMPRSS2:ERG fusion with associated conventional acinar type, suggesting that variant morphology is clonally related to the latter. Overall, our data provide insight into the origin, molecular mechanism, and phenotypic association of ETS fusions in histologic variants of prostate carcinoma.

Original languageEnglish (US)
Pages (from-to)1176-1185
Number of pages10
JournalModern Pathology
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2009

Keywords

  • ETS
  • Fluorescence in situ hybridization
  • Histologic variant
  • Prostate carcinoma
  • Rearrangement

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Han, B., Mehra, R., Suleman, K., Tomlins, S. A., Wang, L., Singhal, N., Linetzky, K. A., Palanisamy, N., Zhou, M., Chinnaiyan, A. M., & Shah, R. B. (2009). Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma. Modern Pathology, 22(9), 1176-1185. https://doi.org/10.1038/modpathol.2009.79